The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells

Relationship between cellular and exosomal miRNAs targeting NOD-like receptors in bladder cancer: preliminary results

(2020) Giulia Poli et al.   Minerva Urologica E Nefrologica

ADAM10 mediates malignant pleural mesothelioma invasiveness

(2019) Christelle Sépult et al.   ONCOGENE

Cancer metabolomic markers in urine: evidence, techniques and recommendations

(2019) Sarah S. Dinges et al.   Nature Reviews Urology

Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo

(2019) Ling Wei et al.   PHARMACOLOGICAL RESEARCH

Clinicopathological impacts of c-Met overexpression in bladder cancer: evidence from 1,336 cases

(2019) Xin Xu et al.   OncoTargets and Therapy

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

(2019) Marko Babjuk et al.   EUROPEAN UROLOGY

Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma

(2018) Fan Feng et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Transcriptional Regulation of the Warburg Effect in Cancer by SIX1

(2018) Ling Li et al.   CANCER CELL

ADAM9 mediates the interleukin-6-induced Epithelial–Mesenchymal transition and metastasis through ROS production in hepatoma cells

(2018) Yinying Dong et al.   CANCER LETTERS

Modulation of oncogenic transcription factors by bioactive natural products in breast cancer

(2018) Mohadeseh Hasanpourghadi et al.   PHARMACOLOGICAL RESEARCH

Long noncoding RNAs act as regulators of autophagy in cancer

(2018) Ting Sun   PHARMACOLOGICAL RESEARCH

Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells

(2018) Yingshi Zhang et al.   Cell Death & Disease

Next Generation Sequencing of urine exfoliated cells: an approach of prostate cancer microRNAs research

(2018) Gabriella Guelfi et al.   Scientific Reports

A universal SNP and small-indel variant caller using deep neural networks

(2018) Ryan Poplin et al.   NATURE BIOTECHNOLOGY

ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR

(2018) Zhiyi Shao et al.   PHARMACOLOGICAL RESEARCH

LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis

(2018) Jing Quan et al.   OncoTargets and Therapy

Procaspase-3-activating compound 1 stabilizes hypoxia-inducible factor 1α and induces DNA damage by sequestering ferrous iron

(2018) Feifei Li et al.   Cell Death & Disease

LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells

(2018) Yan Chen et al.   Cancer Management and Research

Precision medicine for urothelial bladder cancer: update on tumour genomics and immunotherapy

(2017) Kenneth M. Felsenstein et al.   Nature Reviews Urology

Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer

(2017) Ettore Mearini et al.   OncoTargets and Therapy

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis

(2017) Yingchun Liang et al.   Cell Death & Disease

miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14

(2017) Quanbo Ji et al.   Cell Death & Disease

WX-132-18B, a novel microtubule inhibitor, exhibits promising anti-tumor effects

(2017) Fang Guan et al.   Oncotarget

Reduced E-cadherin expression is correlated with poor prognosis in patients with bladder cancer: a systematic review and meta-analysis

(2017) Yongpeng Xie et al.   Oncotarget

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

(2017) Joseph Dosch et al.   Oncotarget

Anti-cancer activity of dose-fractioned mPE +/− bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients

(2017) Pierpaolo Pastina et al.   Journal of Thoracic Disease

Osteopontin induces autophagy to promote chemo-resistance in human hepatocellular carcinoma cells

(2016) Guoke Liu et al.   CANCER LETTERS

Molecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer

(2016) Miles A. Miller et al.   CLINICAL CANCER RESEARCH

Targeting ADAM17 Sheddase Activity in Cancer

(2016) Armando Rossello et al.   CURRENT DRUG TARGETS

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

Considerations on inhibition approaches for proinflammatory functions of ADAM proteases

(2016) Daniela Dreymueller et al.   PLATELETS

ADAM15 Is Functionally Associated with the Metastatic Progression of Human Bladder Cancer

(2016) Guadalupe Lorenzatti Hiles et al.   PLoS One

Expression of inflammasome-related genes in bladder cancer and their association with cytokeratin 20 messenger RNA

(2015) Giulia Poli et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9

(2014) A Y Jia et al.   BRITISH JOURNAL OF CANCER

ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells

(2014) Lin Fu et al.   TUMOR BIOLOGY

Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis

(2011) Ming-Hui Yang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma

(2011) Yu-Chang Tyan et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer

(2010) Letizia Mezzasoma et al.   BMC Urology